Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

6.7%

1 terminated/withdrawn out of 15 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

33%

5 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 1
7(46.7%)
Phase 3
5(33.3%)
Phase 2
3(20.0%)
15Total
Phase 1(7)
Phase 3(5)
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials
NCT07387094Phase 3Recruiting

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

Role: lead

NCT07073417Phase 2Active Not Recruiting

A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

Role: lead

NCT07434050Phase 3Recruiting

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy

Role: lead

NCT07143227Phase 1Active Not Recruiting

A Study of XW003 Injection in Chinese Adolescents With Obesity

Role: lead

NCT07243171Phase 1Recruiting

A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

Role: lead

NCT05680155Phase 3Completed

A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients

Role: lead

NCT05184322Phase 1Completed

XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults

Role: collaborator

NCT05779995Phase 1Completed

A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV

Role: lead

NCT06335134Phase 1Completed

A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin

Role: lead

NCT05680129Phase 3Completed

A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM

Role: lead

NCT05813795Phase 3Completed

A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity

Role: lead

NCT05083117Phase 2Withdrawn

Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy

Role: collaborator

NCT05111912Phase 2Completed

Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

Role: collaborator

NCT05642403Phase 1Completed

A Study of XW001 in Healthy Adult Subjects

Role: lead

NCT04389775Phase 1Completed

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants

Role: collaborator

All 15 trials loaded